BackConstellation Pharmaceuticals Overview

Constellation Pharmaceuticals Other Assets

Latest other assets for CNST: $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average / median

Loading

Constellation Pharmaceuticals Other Assets History

Loading

Constellation Pharmaceuticals vs. peers: Other Assets Comparison

Loading

Constellation Pharmaceuticals Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Constellation Pharmaceuticals (CNST) FAQ

As of the most recent data (March 2021), CNST shows a other assets of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CNST's other assets is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Constellation Pharmaceuticals is outperforming or lagging.

Tracking CNST's other assets over time shows whether Constellation Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has Constellation Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $0) with ownership activity and broader fundamentals.

Constellation Pharmaceuticals's other assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.